(Q34555004)

English

"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

McAreavey D

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ramsey LE

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Latham L

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

McLaren AD

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lorimer AR

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Reid JL

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Robertson JI

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Robertson MP

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Weir RJ

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 January 1984

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

288

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

6411

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

106-111

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Liquid-chromatographic detection of thiazide diuretics in urine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443950

7 July 2018

Minoxidil in the management of intractable hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443950

7 July 2018

Side Effects of Hypotensive Agents Evaluated by a Self-administered Questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443950

7 July 2018

A symptom questionnaire for hypertensive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443950

7 July 2018

A random-zero sphygmomanometer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443950

7 July 2018

Studies with prazosin--a new effective hypotensive agent. I. Open clinical study of prazosin in combination with other antihypertensive agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443950

7 July 2018

Minoxidil for severe hypertension after failure of other hypotensive drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443950

7 July 2018

Labetalol in long-term treatment of hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443950

7 July 2018

Methyldopa and propranolol or practolol in moderate hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443950

7 July 2018

Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443950

28 July 2018

A comparison of minoxidil and hydralazine in non-azotemic hypertensives

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prazosin: Preliminary Report and Comparative Studies with Other Antihypertensive Agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atenolol, methyldopa, and chlorthalidone in moderate hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis for urinary catecholamines by liquid chromatography with amperometric detection: methodology and clinical interpretation of results

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atenolol determination by high-performance liquid chromatography and fluorescence detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prazosin determination by high-pressure liquid chromatography using flourescence detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective high-performance liquid chromatographic assays for hydralazine and its metabolites in plasma of man

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydrallazine in hypertension: is there a safe dose?

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diuretic and beta-blocker in hypertension--then what?

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of refractory hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/6419809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.288.6411.106

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34555004&oldid=1554653842"